Why are you looking at Bioaegis Therapeutics?
Email me when a Bioaegis Therapeutics recompete window opens.
Capability
Service linesIN-VITRO DIAGNOSTIC SUBSTANCE MANUFACTURING · RESEARCH AND DEVELOPMENT IN THE PHYSICAL, ENGINEERING, AND LIFE SCIENCES (EXCEPT NANOTECHNOLOGY AND BIOTECHNOLOGY)
Work mix: 92% prime · 8% sub · primary NAICS 541715 / PSC AN13 HEALTH R&D SERVICES; HEALTH CARE SERVICES; EXPERIMENTAL DEVELOPMENT
Where they win
Sole agencyRecompete exposure: Moderate · 1 in 24mo
Bioaegis Therapeutics has an estimated $20.0M in contracts returning to market over the next 24 months.
Agency buyer map
1 buyersRecompete exposure
ModerateBioaegis Therapeutics has an estimated $20.0M in contracts returning to market over the next 24 months.
Bioaegis Therapeutics teams with
1Partners from federal subaward / teaming records (public).
“SCOUT saves the hours of analysis that capture and proposal teams cannot afford to lose by delivering analyzed intelligence. Incumbent history, competitive positioning, and agency buying patterns get synthesized into…”
Enter your company name and we'll build the page.
Query this company live in SCOUT via MCP — personalized displacement scoring, alerts, and capture workflow. Learn about SCOUT MCP →
Frequently asked questions
What federal contracts does Bioaegis Therapeutics hold?
Bioaegis Therapeutics (UEI G2AZAC2PG7X3) shows $20.0M across 1 award actions in SCOUT’s public USASpending-backed profile, with Department of Health and Human Services (HHS) as the top buying agency. Totals cover federal prime awards ≥$100K in the rolling window.
How much in federal contracts does Bioaegis Therapeutics have?
Bioaegis Therapeutics shows $20.0M across 1 award actions. SCOUT tracks 1 incumbent recompetes ($20.0M) returning to market in the next 24 months.
Which agencies does Bioaegis Therapeutics work with?
Bioaegis Therapeutics’s firm-wide obligated mix is led by Department of Health and Human Services (HHS) (100%).
What is the UEI for Bioaegis Therapeutics?
The Unique Entity ID (UEI) for Bioaegis Therapeutics is G2AZAC2PG7X3.
Does Bioaegis Therapeutics have contracts coming up for recompete?
Yes — SCOUT tracks 1 incumbent recompete in the next 24 months (Moderate exposure). Open the recompete section on this page for PIID-level timing.
Seen enough? Run one full capture cycle on Bioaegis Therapeutics — $90 for 90 days.
This page stays free. Pilot is the live layer: displacement scoring, recompete pipeline, Daily Brief, and SCOUT MCP for 90 days. If you already live in Claude or ChatGPT and only need live search, start MCP Explorer at $29/mo.
$1/day · one payment · no subscription
Use SCOUT in your AI client — $29/moClassify + search inside Claude, ChatGPT, Cursor
Compare plansData: Showing contracts ≥ $100K from federal procurement records (FPDS-NG, SAM.gov, and related repositories), normalized by PrimeRFP SCOUT. Each row keyed by Award ID (PIID); task orders appear as independent rows.